Ki-67 was initially identified as an antigen in the nucleus of Hodgkin’s lymphoma cells, and it is highly expressed in circulating cells but strongly down-regulated in quiescent G0 cells. This evidence concerns the gene MKI67 and Hodgkins lymphoma.